Reckitt Continues Asian Push With $724M Paras Purchase
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.
You may also be interested in...
Sanofi Enters India’s Consumer Market With Universal Medicare Buy
Sanofi’s search for high-growth consumer brands in India led to the firm’s Aug. 24 acquisition of Universal Medicare Pvt. Ltd.’s nutraceutical business.
Takeda Gains Access To European OTC Market With $13.7B Nycomed Buy
Japanese pharma giant Takeda Pharmaceuticals Co. Ltd. gains access to the European OTC market with its $13.7 billion purchase of Swiss firm Nycomed AS.
Reckitt CEO Becht’s Exit Has Analysts Expecting Bumps Ahead
Reckitt Benckiser CEO Bart Becht's retirement sparks concern from market analysts, even with the executive currently in charge of the firm’s leading brands, Rakesh Kapoor, named to take the top post.